Blog - Page 3026 of 5586

WednesdayNov 07, 2012 7:49 pm

Graphite Corp. (GRPH) Makes Key Acquisitions in Rich Montana Graphite, Jumps to 1,700 Acres as Part of Larger Regional Strategy

Graphite Corp., the Elko, Nevada-based junior focused on developing the choice, large-flake graphite for which North America is well-known via the company’s now sizeable holdings in Alabama and Montana (both very mining-friendly states), announced today that they have successfully expanded their land position in Montana at the Crystal Mine site (consisting of a 25-year renewable minerals lease agreement, including 3% net smelter royalty, on 100 acres in Beaverhead County). The company has added some 1,600 acres (83 claims) of adjacent territory on BLM ground. This gives GRPH a contiguous lode mineral claim position on a historically proven (last worked in…

WednesdayNov 07, 2012 7:48 pm

Crown Media Holdings Inc. (CRWN) Video Chart for Wednesday, November 7, 2012

CRWN has posted strong gains across 2012. The stock has been consolidating in a channel around $1.65 to $1.75 for several months and tried to breakout late last week. A pullback has followed, but the chart is being watched for a bounce off the support point to try and continue its upward path. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

WednesdayNov 07, 2012 7:47 pm

AtheroNova, Inc. (AHRO) Welcomes Fred Knoll to Board of Directors

Biotech company AtheroNova today announced Fred Knoll, the principal and portfolio manager of Knoll Capital Management, as the newest member to the board of directors of AtheroNova. Knoll has served in his current position at Knoll Capital since 1987, and was previously employed as an investment manager for General American Investors; was the U.S. representative on investments in leveraged buyouts and venture capital for Murray Johnstone Ltd. of Glasgow, UK; and was head of the New York investment group of UK-based Robert Fleming Inc., which was acquired by JP Morgan. “As a leading investment manager, Fred brings a wealth of…

WednesdayNov 07, 2012 7:45 pm

DoMark International, Inc. (DOMK) is “One to Watch”

DoMark International is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish. Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary’s current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple’s iPad, and the SolaCase, a…

WednesdayNov 07, 2012 7:35 pm

Integrated Freight Corp. (IFCR) Advances Toward Becoming One of the Largest Freight Carriers in U.S.

Integrated Freight Corp., a publicly traded motor freight company headquartered in Sarasota, Fla., is engaged in long-haul, regional, and local service to its customers. Specializing in dry and refrigerated freight truckload services, the company operates chiefly in well-established traffic lanes in the upper Midwest, the Pacific Northwest, Texas, California, and the Atlantic Seaboard. Incorporated in 2008, Integrated Freight was created for the purpose of acquiring and consolidating mid-sized operating motor freight companies. The company currently operates four subsidiaries – Cross Creek Trucking, Inc.; Morris Transportation, Inc.; Smith Systems Transport, Inc.; and Triple C Transport, Inc. – as independent companies under…

WednesdayNov 07, 2012 10:47 am

VistaGen Therapeutics, Inc. (VSTA) Presents Heart Tissue Engineering Progress at American Heart Association 2012 Scientific Sessions

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, today announced that results of their collaboration with Duke University were presented this week at the American Heart Association 2012 Scientific Sessions in Los Angeles. The presentation, entitled “Human embryonic stem cell-derived cardiac tissue patch with advanced structure and function,” illuminated the important synergistic interactions of VistaGen’s stem cell-derived human cardiomyocytes (heart cells) and Duke’s tissue engineering and analytical technologies. The research, which expands the scope of VistaGen’s drug rescue capabilities focused on heart toxicology, was led at Duke by Dr. Nenad…

WednesdayNov 07, 2012 10:46 am

China Sunergy Co. Ltd. (CSUN) Completes Transactions to Procure Two Solar Park Projects in the UK

China Sunergy Co. Ltd., a specialized solar cell and module manufacturer, announced intentions to invest in two 5MW Solar Parks. The solar parks are located in the southwest of Cornwall region in the UK. China Sunergy will arrange the construction of the projects, and then own and operate these two solar parks itself. The two solar parks will be able to achieve high energy output levels that will increase the economic return due to the high irradiation of above 1,000 kWh per square meters a year. The construction of the two solar parks will begin in the upcoming weeks and…

WednesdayNov 07, 2012 10:44 am

Pointer Telocation Ltd. (PNTR): New Collaboration Will Offer Advanced and Profitable Telematics Applications for Public Transit Systems

Cellocator, a Pointer Telocation Ltd. division and a global leader in fleet management and tracking solutions, and iris-GmbH, a leading provider of sensors for automatic people counting, recently announced plans for collaboration that will offer an integrated fleet management and automatic passenger counting solution for use in the public transit market. This collaboration allows for full integration of the iris IRMA Basic system with Cellocator’s Cello-F device, resulting in accurate passenger counting for effective utilization of vehicles in public transit systems, as well as enabling advanced fleet management and fleet safety applications. Cellocator’s Cello-F platform provides superior functionality and performance…

TuesdayNov 06, 2012 10:59 am

Cardium Therapeutics, Inc. (CXM) Reports European Union’s First Gene Therapy Approval

Today, Cardium Therapeutics announced the EU approval of uniQure’s Glybera® (alipogene tiparvovec). This first gene therapy approval by a major health regulatory authority represents a significant milestone and validation for the gene therapy industry. Glybera® was developed to treat patients diagnosed with an inherited metabolic disease called familial lipoprotein lipase deficiency (LPLD or familial hyperchylomicronemia). The European Commission’s marketing authorization of Glybera covers all 27 European member states. uniQure plans to apply for regulatory approval in the U.S., Canada, and other countries. “The EU approval of Glybera represents a major milestone for the global gene therapy industry,” commented Christopher J.…

TuesdayNov 06, 2012 10:58 am

International Stem Cell Corp. (ISCO) to Host Conference Call to Discuss Q3 2012 Financial Results

Earlier this morning, International Stem Cell Corp. announced that it will be hosting a conference call later this week. Dr. Simon Craw, Executive Vice President of International Stem Cell, and Ms. Linh Nguyen, Chief Financial Officer, will be present to discuss ISCO’s financial results for the three months ended September 30, 2012. Those who wish to attend the call should note the information below: Date: Friday, November 9, 2012 Time: 11:00 a.m. Eastern Time Conference Line (U.S.): 1-877-317-6776 International Dial-In: 1-412-317-6776 Conference ID: 10020806 Webcast: http://webcast.mzvaluemonitor.com/Home/Login/630 Investors are advised to dial in at least 10 minutes before the call. Those…

Site Search

Company Search